$ZURA I am in need of post hoc analysis, if you have thoughts, please share. I don’t have the time to do it myself right now.
2
6
1,291
I met this guy recently who does coke everyday and hes still obese. Imagine that. Sit and think about it for a while. If that doesn't inspire you to be great idk.
Why is everyone’s substack paid I think I should make mine paid am I doing something wrong?
2
14
1,559
M retweeted
I gotta say, there's a lot of people coming out and saying that MoAs are often unknown but this really isn't true.
Yes there are exceptions to the rule, but the overwhelmingly majority of drugs MoAs are known. ADCs kill cells with payloads. TCEs leverage t cell killing. Even naked mAbs are exquisitely well described with canonical antibody medicated cell killing and even extra mechanisms like enzyme blocking.
Literally all of rational drug design is predicated on knowing the MoA and designing an agent around it.
I do respect the notion of leveraging poly pharmacology, I did write a 30pg report and do an hour long video on a polyclonal antibody product. But even then it's an exception.
Probably over 3/4 of drug programs in dev are just copy cat me toos. I think we may see slightly more drug dev in a poly pharmacological framework, but this is not going to start taking off for like a dozen very practical reasons in drug dev and if it did it would overhwlmingly end in failure and kill programs/ companies
The reaction to Terence Tao’s cancer thought experiment is revealing. Even brilliant people have a different mental model of how medicine works than those of us inside it. Drugs can deliver benefits beyond anything we anticipated (GLP-1s, anti-PD1), or fall far short of compelling mechanistic rationales. Clinical evidence is probabilistic and mechanistic understanding is incomplete. We undermine trust when we pretend otherwise. @VPrasadMDMPH @anish_koka @venkmurthy @adamcifu









